SHSE:688526 (China)
Â
Class A
Â¥
12.45
-0.040 (-0.32%)
Sep 22
Business Description
Wuhan Keqian Biology Co Ltd
SIC : 2836
ISIN : CNE1000042Q8
Share Class Description:
SHSE:688526: Class ATotal Employee Number:
950Compare
Compare
Traded in other countries / regions
688526.China Index Membership
SSE Composite Index IPO Date
2020-09-22Description
Wuhan Keqian Biology Co Ltd is a Chinese veterinary biotechnology company engaged in the research, development, production, and sale of veterinary biological products, along with animal disease prevention and control technical services. Its core offerings are vaccines and related biologics for livestock and poultry, principally swine and avian vaccines, used by large-scale farms, breeding enterprises, and veterinary clinics across China. The company also provides diagnostic and technical support services tied to disease prevention programs. Revenue is generated mainly through the sale of veterinary vaccines and biological products, supplemented by technical service fees. Its operations and customer base are concentrated in the domestic Chinese market, where demand is driven by the scale and health management needs of the country's intensive animal husbandry sector. The company is listed on the Shanghai Stock Exchange's STAR Market.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 280.46 | |||||
Equity-to-Asset | 0.89 | |||||
Debt-to-EBITDA | 0.02 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 9.07 | |||||
Beneish M-Score | -2.81 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.7 | |||||
3-Year EBITDA Growth Rate | 1.4 | |||||
3-Year EPS without NRI Growth Rate | -2.5 | |||||
3-Year FCF Growth Rate | 2.5 | |||||
3-Year Book Growth Rate | 6.6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 51.68 | |||||
9-Day RSI | 44.73 | |||||
14-Day RSI | 44.73 | |||||
3-1 Month Momentum % | 6.51 | |||||
6-1 Month Momentum % | -14.33 | |||||
12-1 Month Momentum % | -27.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 7.82 | |||||
Quick Ratio | 7.44 | |||||
Cash Ratio | 4.77 | |||||
Days Inventory | 168.34 | |||||
Days Sales Outstanding | 128.16 | |||||
Days Payable | 144.35 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 5.14 | |||||
Dividend Payout Ratio | 1.01 | |||||
3-Year Dividend Growth Rate | 31.3 | |||||
Forward Dividend Yield % | 5.14 | |||||
5-Year Yield-on-Cost % | 5.14 | |||||
Shareholder Yield % | 5.38 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 63.42 | |||||
Operating Margin % | 33.84 | |||||
Net Margin % | 37.61 | |||||
EBITDA Margin % | 42.44 | |||||
FCF Margin % | 38.79 | |||||
OCF Margin % | 54.12 | |||||
ROE % | 7.56 | |||||
ROA % | 6.71 | |||||
ROIC % | 8.82 | |||||
3-Year ROIIC % | 51.58 | |||||
ROC (Joel Greenblatt) % | 22.27 | |||||
ROCE % | 8.35 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 18.36 | |||||
Forward PE Ratio | 12.45 | |||||
PE Ratio without NRI | 20.08 | |||||
Shiller PE Ratio | 13.24 | |||||
Price-to-Owner-Earnings | 26.83 | |||||
PS Ratio | 6.88 | |||||
PB Ratio | 1.44 | |||||
Price-to-Tangible-Book | 1.46 | |||||
Price-to-Free-Cash-Flow | 20.51 | |||||
Price-to-Operating-Cash-Flow | 14.02 | |||||
EV-to-EBIT | 11.1 | |||||
EV-to-EBITDA | 8.29 | |||||
EV-to-Revenue | 4.74 | |||||
EV-to-FCF | 12.21 | |||||
Price-to-GF-Value | 0.91 | |||||
Price-to-Projected-FCF | 0.95 | |||||
Price-to-Graham-Number | 1.13 | |||||
| Price-to-Net-Current-Asset-Value | 2.28 | |||||
| Price-to-Net-Cash | 4.25 | |||||
Earnings Yield (Greenblatt) % | 9.01 | |||||
FCF Yield % | 5.59 | |||||
Forward Rate of Return (Yacktman) % | -3.12 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Wuhan Keqian Biology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 836.279 | ||
| EPS (TTM) (Â¥) | 0.678 | ||
| Beta | 1.2603 | ||
| 3-Year Sharpe Ratio | -0.54 | ||
| 3-Year Sortino Ratio | -0.68 | ||
| Volatility % | 21.66 | ||
| 14-Day RSI | 44.73 | ||
| 14-Day ATR (Â¥) | 0.28635 | ||
| 20-Day SMA (Â¥) | 12.6625 | ||
| 12-1 Month Momentum % | -27.6 | ||
| 52-Week Range (Â¥) | 11.65 - 18 | ||
| Shares Outstanding (Mil) | 466.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Wuhan Keqian Biology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Wuhan Keqian Biology Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.640000 Cash Dividend | 2026-05-26 | 14.19 (+0.07%) | ||
| CNY 0.430000 Cash Dividend | 2025-06-16 | 16.26 (-1.99%) |
Show
Entries
Wuhan Keqian Biology Co Ltd Frequently Asked Questions
What is Wuhan Keqian Biology Co Ltd(SHSE:688526)'s stock price today?
The current price of SHSE:688526 is ¥12.45. The 52 week high of SHSE:688526 is ¥18.00 and 52 week low is ¥11.65.
When is next earnings date of Wuhan Keqian Biology Co Ltd(SHSE:688526)?
The next earnings date of Wuhan Keqian Biology Co Ltd(SHSE:688526) is .
Does Wuhan Keqian Biology Co Ltd(SHSE:688526) pay dividends? If so, how much?
The Dividend Yield %  of Wuhan Keqian Biology Co Ltd(SHSE:688526) is 5.14% (As of Today), Highest Dividend Payout Ratio of Wuhan Keqian Biology Co Ltd(SHSE:688526) was 1.01. The lowest was 0.23. And the median was 0.24. The  Forward Dividend Yield % of Wuhan Keqian Biology Co Ltd(SHSE:688526) is 5.14%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers